[Effect of 2-bromo-alpha-ergocryptine on the response of the hypothalamo-hypophyseal-adrenal system to insulin hypoglycemia in man].
D000293:Adolescent; D000311:Adrenal Glands / Q000187:drug effects*; D000328:Adult; D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology*; D004285:Dogs; D004873:Ergolines / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007003:Hypoglycemia / Q000097:blood*; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects
D004873:Ergolines; D007328:Insulin; D011954:Receptors, Dopamine; D001971:Bromocriptine; D006854:Hydrocortisone
Effetto della 2-bromo-alfa-ergocriptina (CB 154) sulla rispo-sta del sistema ipotalamo-ipofisi-corticosurrene all'ipoglicemia insulinica nell'uomo